Sandeep Kumar

Dr. Sandeep Kumar

Director, Drug Development Consulting

Subject Expert
About

Dr. Sandeep Kumar serves as Director, Drug Development Consulting at Quotient Sciences, where he leads the design of Translational Pharmaceutics® programs and develops product strategies tailored to customer needs. With over 10 years of experience spanning formulation development, clinical trial manufacturing, excipient and coating technologies, Dr. Kumar brings extensive expertise from roles in academia, large and midsize CDMOs, and the excipient industry.

He is an inventor on multiple formulation patents and has authored numerous research articles. Dr. Kumar’s expertise covers the full spectrum of drug product development—from early-stage formulation through to late-stage development and commercial readiness. He is particularly passionate about supporting early-stage drug development customers in bringing differentiated products to market.

Dr. Kumar holds a Ph.D. in Pharmacy from Queen’s University Belfast, Northern Ireland, UK. His commitment to scientific excellence and customer-focused solutions ensures that clients benefit from robust, efficient, and innovative drug development pathways.

Quotient Sciences Logo
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers

The Strategic Role of Drug Development Consultants at Quotient Sciences

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More